Palouse Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Palouse Capital Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$775.18 - $881.7 $6,201 - $7,053	-8 Reduced 0.62%	1,286 $1.13 Million
Q3 2023 Oct 23, 2023	BUY	$692.45 - $844.37 $2,769 - $3,377	4 Added 0.31%	1,294 $1.06 Million
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $53,202 - $63,106	-76 Reduced 5.56%	1,290 $926,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $270,154 - $328,307	-397 Reduced 22.52%	1,366 $1.12 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $390,357 - $423,813	-553 Reduced 23.88%	1,763 $1.27 Million
Q3 2022 Oct 21, 2022	SELL	$573.97 - $724.32 $39,029 - $49,253	-68 Reduced 2.85%	2,316 $1.6 Million
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $329,558 - $444,042	-601 Reduced 20.13%	2,384 $1.41 Million
Q1 2022 Apr 21, 2022	SELL	$595.12 - $698.43 $70,224 - $82,414	-118 Reduced 3.8%	2,985 $2.09 Million
Q4 2021 Jan 25, 2022	BUY	$543.48 - $670.97 $269,022 - $332,130	495 Added 18.98%	3,103 $1.96 Million
Q3 2021 Oct 21, 2021	SELL	$574.03 - $680.96 $2.14 Million - $2.54 Million	-3,730 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$472.8 - $558.54 $23,640 - $27,927	50 Added 1.36%	3,730 $2.08 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $1.64 Million - $2.02 Million	3,680 New	3,680 $1.74 Million

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Palouse Capital Management, Inc. with notifications on news.